RIVERSIDE, Calif., Sept. 1, 2022 /PRNewswire/ — This week, a federal judge in California issued a landmark decision siding with the California Stem Cell Treatment Center (CSCTC) in a lawsuit brought by the U.S. Food and Drug Administration, ruling that Cell Surgical Network’s innovative surgical procedure that uses patients’ stem cells to treat a range of medical conditions does not fall under the FDA’s regulatory jurisdiction.
